Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 2733-2739

  Johnson, James R ^a,b,f   Menard, Megan ^a,b   Johnston, Brian ^a,b   Kuskowski, Michael A ^a,c   Nichol, Kim ^d   Zhanel, George G ^d,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; ESCHERICHIA COLI; GENOTYPE; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; URINARY TRACT INFECTION; URINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CANADA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 67649910490     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00297-09     Document Type: Article

References (34)

1. Berg, D. E., N. S. Akopyants, and D. Kersulyte. 1994. Fingerprinting microbial genomes using the RAPD or AP-PCR method. Methods Mol. Cell. Biol. 5:13-24.
2. Burman, W. J., P. E. Breese, B. E. Murray, K. V. Singh, H. A. Batal, T. D. MacKenzie, J. W. Ogle, M. L. Wilson, R. R. Revers, and P. S. Mehler. 2003. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am. J. Med. 115: 358-364.
3. Cagnacci, S., L. Gualco, E. Debbia, G. C. Schito, and A. Marchese. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612.
4. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66: 4555-4558.
5. Clermont, O., J. R. Johnson, M. Menard, and E. Denamur. 2007. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn. Microbiol. Infect. Dis. 57:129-136.
6. Clermont, O., M. Lavollay, S. Vimont, C. Deschamps, C. Forestier, C. Branger, E. Denamur, and G. Arlet. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028.
7. Coque, T. M., A. Novais, A. Carattoli, L. Poirel, J. Pitout, L. Peixe, F. Baquero, R. Canton, and P. Nordmann. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
8. Dalmau, D., F. Navarro, B. Mierlis, J. Blanco, J. Garau, and G. Prats. 1996. Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen. J. Hosp. Infect. 34:233-234. (Letter.)
9. Garau, J., M. Xercavins, M. Rodriguez-Carballeira, J. Gomez-Vera, I. Coll, D. Vidal, T. Llovet, and A. Ruiz-Bremon. 1999. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob. Agents Chemother. 43:2736-2741.
10. Gupta, K., T. M. Hooton, and W. E. Stamm. 2001. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135:41-50.
11. Johnson, J. R., B. Johnston, M. A. Kuskowski, J. P. Nougayrede, and E. Oswald. 2008. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J. Clin. Microbiol. 46:3906-3911.
12. Johnson, J. R., A. R. Manges, T. T. O'Bryan, and L. R. Riley. 2002. A disseminated multi-drug resistant clonal group of extraintestinal pathogenic Escherichia coli as a cause of pyelonephritis. Lancet 359:2249-2251.
13. Johnson, J. R., A. C. Murray, M. A. Kuskowski, S. Schubert, M.-F. Prere, B. Picard, R. Colodner, R. Raz, and Trans-Global Initiative for Antimicrobial Resistance Analysis (TIARA) Investigators. 2005. Distribution and characteristics of Escherichia coli clonal group A. Emerg. Infect. Dis. 11:141-145.
14. Johnson, J. R., K. Owens, A. R. Manges, and L. W. Riley. 2004. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J. Clin. Microbiol. 42:2618-2622.
15. Johnson, J. R., K. Owens, T. T. O'Bryan, M. Sabate, and G. Prats. 2004. Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR. J. Clin. Microbiol. 42:3841-3843.
16. Johnson, J. R., and A. L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272.
17. Johnson, J. R., A. L. Stell, T. T. O'Bryan, M. Kuskowski, B. Nowicki, C. Johnson, J. M. Maslow, A. Kaul, J. Kavle, and G. Prats. 2002. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J. Clin. Microbiol. 40:1913-1923.
18. Johnson, J. R., A. L. Stell, F. Scheutz, T. T. O'Bryan, T. A. Russo, U. B. Carlino, C. C. Fasching, J. Kavle, L. van Dijk, and W. Gaastra. 2000. Analysis of F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect. Immun. 68:1587-1599.
19. Karlowsky, J. A., S. Kasloff, K. A. Nichol, D. J. Hoban, and G. G. Zhanel. 2007. Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens. Diagn. Microbiol. Infect. Dis. 58:283-287.
20. Leflon-Guibout, V., J. Blanco, K. Amaqdouf, A. Mora, L. Guize, and M. H. Nicolas-Chanoine. 2008. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 46: 3900-3905.
21. Leflon-Guibout, V., C. Jurand, S. Bonacorsi, F. Espinasse, M. C. Guelfi, F. Duportail, B. Heym, E. Bingen, and M. H. Nicolas-Chanoine. 2004. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob. Agents Chemother. 48:3736-3742.
22. Manges, A. R., J. R. Johnson, B. Foxman, T. T. O'Bryan, K. E. Fullerton, and L. W. Riley. 2001. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345:1007-1013.
23. Manges, A. R., H. Tabor, P. Tellis, C. Vincent, and P. P. Tellier. 2008. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg. Infect. Dis. 14:1575-1583.
24. Nicolas-Chanoine, M. H., J. Blanco, V. Leflon-Guibout, R. Demarty, M. P. Alonso, M. M. Canica, Y. J. Park, J. P. Lavigne, J. Pitout, and J. R. Johnson. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
25. O'Neill, P. M., C. A. Talboys, A. P. Roberts, and B. S. Azadian. 1990. The rise and fall of Escherichia coli O15 in a London teaching hospital. J. Med. Microbiol. 33:23-27.
26. Phillips, I., S. Eykyn, A. King, W. R. Grandsden, B. Rowe, J. A. Frost, and R. J. Gross. 1988. Epidemic multiresistant Escherichia coli infection in West Lambeth health district. Lancet i:1038-1041.
27. Pitout, J. D., D. L. Church, D. B. Gregson, B. L. Chow, M. McCracken, M. R. Mulvey, and K. B. Laupland. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286.
28. Pitout, J. D., P. Nordmann, K. B. Laupland, and L. Poirel. 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59.
29. Prats, G., F. Navarro, B. Mirelis, D. Dalmau, N. Margall, P. Coll, A. Stell, and J. R. Johnson. 2000. Escherichia coli serotype O15:K52:H1 as a uropathogenic clone. J. Clin. Microbiol. 38:201-209.
30. Sannes, M. R., M. San Roman, J. Moya, N. Mora, A. A. Eckhoff, D. N. Williams, J. R. Johnson, and P. K. Peterson. 2003. Antimicrobial resistance among Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int. J. Antimicrob. Agents 21:79-82.
31. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Muray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Wallace-Gadsden, F., J. R. Johnson, J. Wain, and I. N. Okeke. 2007. Enteroaggregative Escherichia coli related to uropathogenic clonal group A. Emerg. Infect. Dis. 13:757-760.
33. Zhanel, G. G., T. L. Hisanaga, N. M. Laing, M. R. DeCorby, K. A. Nichol, L. P. Palatnik, J. Johnson, A. Noreddin, G. K. Harding, L. E. Nicolle, and D. J. Hoban. 2005. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 26:380-388.
34. Zhanel, G. G., T. L. Hisanaga, N. M. Laing, M. R. DeCorby, K. A. Nichol, B. Weshnoweski, J. Johnson, A. Noreddin, D. E. Low, J. A. Karlowsky, and D. J. Hoban. 2006. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 27:468-475.